We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: orth America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Therapeutic indications
Treatment of infections caused by penicillin-sensitive Gram-positive bacteria as well as H, Influenzas,
E Coli, P Mirabilis, Salmonella and some Shigellosis species. Treatment of bronchitis, otitis media, bacterial pharyngitis, bacterial pneumonia, sinusitis, urinary tract infections.
Dose and method of administration
Capsules: 500mg every eight hours. The usual adult prescribing limits are 4, 5 g a day.
bacterial endocarditis, meningitis or septicaemia I to 2 every 3 to 4 hours; listeriosis 50 mg per kg of body weight 6 hours. Neonates up to 2 kgof body weight 25 to 50 mg every 12 hours during the first week of life thereafter 50 mg every eight hours. Nconates over 2 kg 50 mgper kg of body weight every 8 hours during the first week of life thereafter every six hours. Infant up to 20 kg 12, 5 mg per kg of body weight every 6 hours. Infant over 20 kg should receive the usual adult dose.
Contraindications:
Known history of hypcrsensitivity or allergic reactions to any of the penicillins.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
